Zlúčenina výskumnej kvality. Len na laboratórne použitie. Nie je určená na použitie u ľudí alebo zvierat, na požitie ani na injekciu. Nevyslovujú sa ani neimplikujú žiadne medicínske tvrdenia.
Adipotide
Doprava zdarma pri objednávkach nad €200
- Ak produkt nezodpovedá špecifikácii uvedenej v jeho zverejnenom COA, kontaktujte nás s číslom šarže: preveríme ho voči správe danej šarže a bezplatne nahradíme každý produkt, ktorý jej nevyhovuje.
- Kontaktujte nás do 48 hodín od doručenia a priložte fotografie vonkajšej škatule, vnútorného balenia a všetkých dotknutých liekoviek s čitateľnými štítkami. Potvrdené poškodenie počas prepravy nahradíme bezplatne.
3–7 dní do väčšiny krajín EÚ · 10–14 dní do severských krajín a pobaltských štátov
Štandardná doprava v EÚ od 4,99 € (RO) · hlavná EÚ (GLS) 17,99 € · severské krajiny a pobaltské štáty 12,99 € – 15,99 € · Odoslanie do 1–2 pracovných dní · Doprava zdarma nad 200,00 € · bez colnej dokumentácie (EÚ) · prostredníctvom siete dopravcov v EÚ
Ešte 200,00 € do dopravy zdarma nad 200,00 €. Pod touto sumou stojí štandardná doprava v EÚ 17,99 € (GLS, väčšina EÚ).
Ako fungujú Paysera a SEPA
- Zaplaťte: odošlite manuálny prevod SEPA na IBAN, ktorý vám zašleme e-mailom, alebo, ak to pokladňa pre vašu adresu ponúka, schváľte prevod SEPA vo vlastnej banke cez hostovanú stránku Paysera.
- Potvrdíme: Paysera nás okamžite upozorní, alebo manuálny prevod spárujeme, keď dorazí (zvyčajne 1 pracovný deň).
- Expedujeme: potvrdené objednávky zvyčajne odosielame do 1-2 pracovných dní.
Platby kartou momentálne neponúkame. Táto pokladňa nepoužíva žiadneho spracovateľa platieb kartou.
Research-grade Adipotide. Class-level specification ≥98%. Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.
Dôležité upozornenie
Tento produkt je určený len na laboratórne a výskumné použitie. Nie je určený na použitie u ľudí ani vo veterinárnej medicíne. Nákupom potvrdzujete, že tento produkt bude použitý výhradne na in-vitro výskumné účely.
Z dôvodu právnych a regulačných požiadaviek nie je možné tento produkt odoslať do: Chorvátsko, Litva, Slovinsko a Taliansko.
Vyžaduje sa rekonštitúcia
Tento peptid sa expeduje lyofilizovaný (suchý prášok) a pred použitím vyžaduje rekonštitúciu bakteriostatickou vodou. BAC voda sa predáva samostatne.
Kedy tento produkt nemusí vyhovovať vášmu výskumu
- ⚠Ak váš výskum vyžaduje materiál kvality GMP pre klinické aplikácie — peptidy výskumnej kvality nie sú určené na klinické použitie.
- ⚠Ak vaše laboratórium nemá vhodné chladené skladovanie (mraznička -20°C) — stabilita tohto peptidu môže byť pri vyšších teplotách narušená.
- ⚠Ak váš študijný protokol vyžaduje referenčné štandardy schválené FDA — obráťte sa na USP alebo na poskytovateľa certifikovaného referenčného materiálu.
Pre vybrané šarže sú zverejnené laboratórne správy. V každej správe si overte výsledok a uvedenú metódu. Len na výskumné účely.
Správa Janoshik zverejnená, keď bude k dispozícii
Expedícia do 1–2 pracovných dní, doprava od 4,99 € v Rumunsku, od 12,99 € vo zvyšku Európy
Evidovaná špecifikácia na úrovni triedy; nezávislá správa Janoshik pre vybrané šarže
O produkte Adipotide
For research purposes only. Not for human or veterinary use.
Overview
Adipotide (also written as FTPP, or by its sequence CKGGRAKDC-GG-D(KLAKLAK)2) is a proapoptotic peptidomimetic built for vascular targeting of white adipose tissue. Two functional halves are joined in a single molecule: a homing peptide, CKGGRAKDC, that binds prohibitin displayed on the endothelium of blood vessels feeding white fat, and a proapoptotic domain, D(KLAKLAK)2, that disrupts mitochondrial membranes once it is internalised. The homing sequence was originally isolated through in vivo phage-display screening for peptides that localise to white adipose tissue vasculature, which is what gives the conjugate its tissue selectivity in research models.
The molecule was characterised by researchers at the University of Texas MD Anderson Cancer Center. It is frequently discussed as a conceptual parallel to antibody-drug conjugates: the cytotoxic payload is only delivered where the targeting element has bound, so activity is concentrated at the intended vascular bed rather than distributed systemically. CertaPeptides is a reseller and supplies Adipotide as a research reagent; we do not manufacture, formulate, or select the salt form of this compound.
Research Areas
Published literature has investigated Adipotide primarily as a tool for studying adipose-tissue vascular biology and the metabolic consequences of ablating fat-feeding vasculature. In the foundational mouse work, targeted ablation of adipose vasculature was used to study adipose-tissue remodelling and established prohibitin on adipose endothelium as an addressable target (Kolonin et al., 2004). A later non-human primate study examined tissue selectivity, metabolic parameters and renal markers (Barnhart et al., 2011). These two datasets remain the most cited reference points for researchers modelling vascular-targeting approaches to adipose tissue. Typical research questions include how selective prohibitin targeting is across different vascular beds, how model organisms respond to adipose vascular ablation, and how the conjugate format governs where apoptosis is triggered.
Specifications
| Compound | Adipotide / CKGGRAKDC-GG-D(KLAKLAK)2 |
|---|---|
| Purity | ≥98% (class-level specification) |
| Format | Lyophilized powder |
| Reconstitution | Sterile water or PBS |
| Storage | −20°C lyophilized; 2–8°C after reconstitution, use within 14 days |
Quality & Verification
The class-level specification on record is ≥98%. No independent report is on record for this product yet; independent reports on selected lots are searchable by batch or report code at certapeptides.com/verify. We make no in-house testing claim and do not test every batch. EU-based handling under CERTALAB S.R.L.
Frequently Asked Questions
What is adipotide used for in research?
In the published literature, adipotide is used as a research tool to study vascular targeting of white adipose tissue. It combines a peptide that homes to prohibitin on adipose-feeding blood vessels with a proapoptotic domain, letting researchers investigate what happens in model systems when that specific vasculature is ablated. It is supplied for laboratory research only and is not for human or veterinary use.
How does adipotide target fat tissue specifically?
The CKGGRAKDC portion of the molecule was identified through in vivo phage-display screening for peptides that home to white adipose tissue vasculature. Its target, prohibitin, is displayed on the endothelium of fat-feeding vessels. Once the homing peptide binds, the D(KLAKLAK)2 domain is internalised and disrupts mitochondrial membranes, so activity is concentrated at the targeted vascular bed rather than distributed broadly.
What did the primate study report?
Barnhart and colleagues (2011, Science Translational Medicine) studied adipotide in rhesus monkeys, reporting on tissue selectivity, metabolic parameters and renal markers in the model animals. This primate dataset is the most advanced preclinical reference point cited for the compound.
What is a proapoptotic peptide-drug conjugate?
It is a molecule that pairs a targeting peptide with a cell-death-inducing payload, conceptually similar to an antibody-drug conjugate. In adipotide, the targeting peptide delivers the D(KLAKLAK)2 domain to adipose endothelial cells; the payload only acts where the targeting element has bound, which is the source of the conjugate's selectivity in research models.
How should adipotide be stored?
Store the lyophilized powder at −20°C, protected from light. After reconstitution with sterile water or PBS, keep refrigerated at 2–8°C and use within roughly 14 days. Handle in line with standard peptide-handling and institutional biosafety guidelines.
For research purposes only. Not for human consumption.
Súhrn špecifikácie
O produkte Adipotide
For research purposes only. Not for human or veterinary use.
Overview
Adipotide (also written as FTPP, or by its sequence CKGGRAKDC-GG-D(KLAKLAK)2) is a proapoptotic peptidomimetic built for vascular targeting of white adipose tissue. Two functional halves are joined in a single molecule: a homing peptide, CKGGRAKDC, that binds prohibitin displayed on the endothelium of blood vessels feeding white fat, and a proapoptotic domain, D(KLAKLAK)2, that disrupts mitochondrial membranes once it is internalised. The homing sequence was originally isolated through in vivo phage-display screening for peptides that localise to white adipose tissue vasculature, which is what gives the conjugate its tissue selectivity in research models.
The molecule was characterised by researchers at the University of Texas MD Anderson Cancer Center. It is frequently discussed as a conceptual parallel to antibody-drug conjugates: the cytotoxic payload is only delivered where the targeting element has bound, so activity is concentrated at the intended vascular bed rather than distributed systemically. CertaPeptides is a reseller and supplies Adipotide as a research reagent; we do not manufacture, formulate, or select the salt form of this compound.
Research Areas
Published literature has investigated Adipotide primarily as a tool for studying adipose-tissue vascular biology and the metabolic consequences of ablating fat-feeding vasculature. In the foundational mouse work, targeted ablation of adipose vasculature was used to study adipose-tissue remodelling and established prohibitin on adipose endothelium as an addressable target (Kolonin et al., 2004). A later non-human primate study examined tissue selectivity, metabolic parameters and renal markers (Barnhart et al., 2011). These two datasets remain the most cited reference points for researchers modelling vascular-targeting approaches to adipose tissue. Typical research questions include how selective prohibitin targeting is across different vascular beds, how model organisms respond to adipose vascular ablation, and how the conjugate format governs where apoptosis is triggered.
Specifications
| Compound | Adipotide / CKGGRAKDC-GG-D(KLAKLAK)2 |
|---|---|
| Purity | ≥98% (class-level specification) |
| Format | Lyophilized powder |
| Reconstitution | Sterile water or PBS |
| Storage | −20°C lyophilized; 2–8°C after reconstitution, use within 14 days |
Quality & Verification
The class-level specification on record is ≥98%. No independent report is on record for this product yet; independent reports on selected lots are searchable by batch or report code at certapeptides.com/verify. We make no in-house testing claim and do not test every batch. EU-based handling under CERTALAB S.R.L.
Frequently Asked Questions
What is adipotide used for in research?
In the published literature, adipotide is used as a research tool to study vascular targeting of white adipose tissue. It combines a peptide that homes to prohibitin on adipose-feeding blood vessels with a proapoptotic domain, letting researchers investigate what happens in model systems when that specific vasculature is ablated. It is supplied for laboratory research only and is not for human or veterinary use.
How does adipotide target fat tissue specifically?
The CKGGRAKDC portion of the molecule was identified through in vivo phage-display screening for peptides that home to white adipose tissue vasculature. Its target, prohibitin, is displayed on the endothelium of fat-feeding vessels. Once the homing peptide binds, the D(KLAKLAK)2 domain is internalised and disrupts mitochondrial membranes, so activity is concentrated at the targeted vascular bed rather than distributed broadly.
What did the primate study report?
Barnhart and colleagues (2011, Science Translational Medicine) studied adipotide in rhesus monkeys, reporting on tissue selectivity, metabolic parameters and renal markers in the model animals. This primate dataset is the most advanced preclinical reference point cited for the compound.
What is a proapoptotic peptide-drug conjugate?
It is a molecule that pairs a targeting peptide with a cell-death-inducing payload, conceptually similar to an antibody-drug conjugate. In adipotide, the targeting peptide delivers the D(KLAKLAK)2 domain to adipose endothelial cells; the payload only acts where the targeting element has bound, which is the source of the conjugate's selectivity in research models.
How should adipotide be stored?
Store the lyophilized powder at −20°C, protected from light. After reconstitution with sterile water or PBS, keep refrigerated at 2–8°C and use within roughly 14 days. Handle in line with standard peptide-handling and institutional biosafety guidelines.
For research purposes only. Not for human consumption.
Súvisiace výskumné čítanie
Objektívne porovnania a výskumné príručky o tejto zlúčenine. Referenčný materiál len na výskumné použitie.
Dôvera výskumníkov
Prečo si výskumníci vyberajú CertaPeptides
Kto to vlastne testuje?
Vybrané loty nezávisle overuje spoločnosť Janoshik Analytical (Česká republika) a sú zverejnené na verejnom portáli Janoshik. Ostatné loty sa dodávajú s dodávateľskou špecifikáciou šarže. Zverejnenú prehľadovú stenu nájdete na /coa.
Zobraziť COA →Čo ak dostanem nesprávnu šaržu?
Etiketa každej liekovky nesie kód. Vyhľadajte ho na našej overovacej stránke: tá zobrazí, čo k tomuto kódu CertaPeptides zverejňuje, a pri stiahnutej šarži aj to, že bola stiahnutá, a prečo. Ak je vaša šarža stiahnutá alebo ak vyhľadanie kódu z vašej etikety nič nenájde, pošlite nám tento kód e-mailom.
Zobraziť COA →Odkiaľ sa odosiela?
Z Rumunska (EÚ). Sme CERTALAB SRL, CUI 54169956, registrovaní pre DPH. Sameday pre Rumunsko, GLS pre väčšinu destinácií v EÚ, TCE Worldwide pre zvyšné cezhraničné EÚ a mimoúnijné trhy (Spojené kráľovstvo, Švajčiarsko). Doručenie 1–15 pracovných dní v závislosti od destinácie — presné okno sa zobrazí v pokladni.
Podrobnosti o doprave →Čo ak nastane problém?
Máte 14-dňové právo na odstúpenie od zmluvy podľa OUG 34/2014 (rumunské/EÚ spotrebiteľské právo), s možnosťou eskalácie na ANPC a alternatívneho riešenia sporov (SAL). Kontaktujte nás na support@certapeptides.com.
Zásady vrátenia tovaru →Informácie o produkte
Tento produkt je určený výhradne na účely vedeckého výskumu a vývoja. Ide o chemickú látku, ktorá sa nesmie používať ako liek, liečivo, účinná látka ani zložka akéhokoľvek produktu určeného na ľudskú alebo zvieraciu konzumáciu. Výskumníci musia s touto zlúčeninou manipulovať v súlade so svojimi inštitucionálnymi zásadami biologickej bezpečnosti. Používajte len v riadne vybavených laboratórnych priestoroch s vhodnými osobnými ochrannými prostriedkami.
